EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis

Mankia, Kulveer; Siddle, Heidi J; Kerschbaumer, Andreas; Alpizar Rodriguez, Deshire; Catrina, Anca Irinel; Cañete, Juan D; Cope, Andrew P; Daien, Claire Immediato; Deane, Kevin D; El Gabalawy, Hani; Finckh, Axel; Holers, V Michael; Koloumas, Marios; Ometto, Francesca; Raza, Karim; Zabalan, Condruta; van der Helm-van Mil, Annette; van Schaardenburg, Dirkjan; Aletaha, Daniel; Emery, Paul

doi:10.1136/annrheumdis-2021-220884

Scientific article

English

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis

Published inAnnals of the Rheumatic Diseases, vol. 80, no. 10, p. 1286-1298

Publication date2021

Keywords

arthritis
autoantibodies
autoimmunity
rheumatoid

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Recherche clinique en rhumatismes inflammatoires (1010)

Citation (ISO format)

MANKIA, Kulveer et al. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. In: Annals of the Rheumatic Diseases, 2021, vol. 80, n° 10, p. 1286–1298. doi: 10.1136/annrheumdis-2021-220884